Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Terns Pharmaceuticals (NASDAQ: TERN) said senior management will participate in multiple investor conferences in March 2026, including TD Cowen, Leerink, Barclays, and The Citizens Life Sciences conferences.
Rhea-AI Summary
Terns Pharmaceuticals (NASDAQ: TERN) said senior management will participate in multiple investor conferences in March 2026, including TD Cowen, Leerink, Barclays, and The Citizens Life Sciences conferences. Live fireside chat webcasts and replays will be available on the company's investor relations site for at least 30 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TERN
On Feb 26, the first trading day after this news, TERN closed 1.11% below the previous close.
Data tracked by StockTitan Argus for the Feb 26 session.
Key Figures
- TD Cowen conference time
- 3:50 p.m. ET
- TD Cowen 46th Annual Health Care Conference, March 2, 2026
- Leerink conference time
- 1:40 p.m. ET
- Leerink Global Healthcare Conference, March 9, 2026
- Citizens conference time
- 9:00 a.m. ET
- Citizens Life Sciences Conference, March 11, 2026
- Webcast archive period
- 30 days
- Duration webcasts remain archived on company website
Historical Context
-
Equity options granted to new employees under inducement award plan.
-
Outlined 2026 priorities and detailed TERN-701 clinical and cash runway plans.
-
Stock options granted to new employees under Nasdaq Listing Rule 5635(c)(4).
-
Closed underwritten public offering including full exercise of underwriters’ option.
-
Priced upsized public offering of common stock at $40.00 per share.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FOSTER CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be participating in the following upcoming investor conferences in March.
TD Cowen's 46th Annual Health Care Conference
Format: Fireside Chat
Date and Time: Monday, March 2, 2026 at 3:50 p.m. ET
Location: Boston, MA
Leerink Global Healthcare Conference
Format: Fireside Chat
Date and Time: Monday, March 9, 2026 at 1:40 p.m. ET
Location: Miami, FL
Barclays 28th Annual Global Healthcare Conference
Format: 1x1 Meetings
Date: Tuesday, March 10, 2026
Location: Miami, FL
The Citizens Life Sciences Conference
Format: Fireside Chat
Date and Time: Wednesday, March 11, 2026 at 9:00 a.m. ET
Location: Miami, FL
Live webcasts of the fireside chats will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentations.
About Terns Pharmaceuticals
Terns Pharmaceuticals is a clinical-stage oncology company reimagining known biology to deliver high impact medicines. Our lead program TERN-701 is a highly selective, allosteric BCR-ABL inhibitor with a potentially best-in-disease profile that could meaningfully improve upon the efficacy, safety and convenience of existing treatments for CML. For more information, please visit: www.ternspharma.com.
Contacts for Terns
Investors
Justin Ng
investors@ternspharma.com
Media
Jenna Urban
CG Life
media@ternspharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.